Abstract 245P
Background
Currently, the ambiguous role of neutrophils (Nph) in renal cancer (RC), which is determined by their phenotype, is of considerable interest. TGF-β is able to change the expression of pro-inflammatory cytokines of Nph and their receptors, as well as stimulate the production of chemokines that attract Nph to the site of inflammation, thus forming a pro-tumor phenotype (N2). TGF-β in the tumor microenvironment induces the migration of the CD11b+ Nph population. CD11b provides adhesion, migration, degranulation of Nph. Therefore, the study was aimed at assessing the expression of the TGF-β gene, as well as CD11b receptors, by circulating Nph at different stages of RC.
Methods
The study included patients with stage I-II (n=20), stage III-IV (n=20) clear cell RC (Med 62 years) and 20 - control group (CG) (Med 60 years). The study was approved by the Ethics Committee of the IME&PС of UlSU (prot. No. 1, 01/15/2020). RNA was isolated from the fraction of peripheral blood Nph on SileksMagNA magnetic particles (Sileks, Russia). After isolation, a reverse transcription reaction was performed. Expression of the TGF-β gene was determined by quantitative reverse transcription PCR using primers (Evrogen, Russia). Immunophenotyping was performed using monoclonal antibodies to the surface antigen CD11b (Sorbent, Russia). The results were expressed as Med (Q1-Q3). Statistical processing was performed using the Statistica 13, using the Mann–Whitney U-test and the Spearman correlation coefficient (p<0.05).
Results
A significant increase in the expression of the TGF-β gene in Nph was found in patients with RC compared with the CG (0.07 (0.12-2.21) vs 0.05 (0.04-0.13), p=0, 008), and also depending on the stage: at I-II stages of RC 0.43 (0.09-1.21), at III-IV 1.91 (0.87-3.18) (p=0.05). A significant increase in the expression of CD11b on the surface of Nph was found in patients with RC 73.3±5.1% vs the CG 19.0±9.3% (p=0.001), while no relationship with the stage was found. A direct correlation was found between TGF-β and CD11b gene expression in Nph (r=0.48, p=0.01).
Conclusions
In RC, the affinity of circulating neutrophils to the tumor microenvironment increases. At the same time, the level of expression of the growth factor TGF-β increases in Nph.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
238P - Enfortumab-vedotin for metastatic urothelial carcinoma refractory to platinum-based chemotherapy and immune checkpoint inhibitors: A single institution experience
Presenter: Yuki Endo
Session: Poster Display
Resources:
Abstract
239P - Elevated baseline C-reactive protein is a prognostic indicator for OS in patients with metastatic non clear cell renal cell carcinoma treated with systemic therapy
Presenter: Ryuichi Mizuno
Session: Poster Display
Resources:
Abstract
240P - Efficacy and safety of first-line combination therapy with ipilimumab + nivolumab for metastatic renal cell carcinoma in a single institution in Japan
Presenter: Naoya Nagaya
Session: Poster Display
Resources:
Abstract
241P - First-line cabozantinib in metastatic renal cell carcinoma (mRCC): A real-world exploratory study from eastern India
Presenter: Tamojit Chaudhuri
Session: Poster Display
Resources:
Abstract
244P - Clinicopathologic feature and treatment outcome of metastatic non clear cell kidney cancer: A single centre experience from India
Presenter: Somnath Roy
Session: Poster Display
Resources:
Abstract
246P - Impact of renal impairment on first-line treatment in metastatic urothelial cancer
Presenter: Stephanie Wakeling
Session: Poster Display
Resources:
Abstract
247P - Adjuvant chemoradiotherapy in the management of bladder adenocarcinoma compared to multiple treatment modalities
Presenter: Othman Mohammed
Session: Poster Display
Resources:
Abstract
248P - Screening zinc homeostasis-related genes identifies metallothionein 1H (MT1H) as a potential prognostic biomarker in clear cell renal cell carcinoma (ccRCC)
Presenter: Eyad Al Masoud
Session: Poster Display
Resources:
Abstract
249P - The prognostic utility of Progestogen associated Endometrial protein (PAEP) gene expression in clear cell renal cell carcinoma (ccRCC)
Presenter: Leen Lataifeh
Session: Poster Display
Resources:
Abstract
250P - Impact of adjuvant chemo(radio)therapy in stage I/II testicular seminoma
Presenter: Mahmoud Eleisawy
Session: Poster Display
Resources:
Abstract